Products

Compare Products

Side-by-side comparison of veterinary products

1 Products
Librela
Librela
Biological

Injection

Zoetis

Bedinvetmab

Search to add a product

Search to add a product

Attribute Librela
Image Librela
Trade Name Librela

ليبريلا
Product Type Biological
Dosage Form Injection
Manufacturer Zoetis
Active Ingredients
Diseases —
Package Size Vials containing 5 mg, 10 mg, 15 mg, 20 mg, or 30 mg bedinvetmab in 1 mL aqueous solution (packs of 2 vials)
Storage Conditions Store refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
Dosages

Dog

  • 0.5 – 1.0 mg/kg body weight based on dosing table (Subcutaneous (SC)) — Once monthly (every 28 days)
Withdrawal Periods —
Indications
  • Control and alleviation of pain associated with osteoarthritis in dogs.
Contraindications
  • Do not use in dogs with known hypersensitivity to bedinvetmab.
  • Do not use in breeding, pregnant, or lactating dogs.
  • Do not use in dogs under 12 months of age.
Precautions
  • Bedinvetmab may cross the placental barrier and be excreted in milk; therefore do not use in breeding animals.
  • Monoclonal antibodies are eliminated via normal cellular catabolism with minimal involvement of renal or hepatic pathways.
  • Transient pain at the injection site may be observed.
Side Effects
  • Mild swelling at the injection site, urinary tract infections, increased blood urea nitrogen (BUN), dermatitis, and lameness.

This website uses cookies to ensure you get the best experience.